bavituximab

Encouraging News for Peregrine Pharma

Encouraging News for Peregrine Pharma

Yahoo/Zacks

Peregrine Pharma agrees with FDA on lung cancer trial design

Peregrine Pharma agrees with FDA on lung cancer trial design

Reuters

Peregrine's Epic Failure (Maybe)

Peregrine's Epic Failure (Maybe)

Motley Fool

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

Peregrine Pharma Is Wasting Money On A Placebo Cancer Drug

TheStreet.com

Peregrine Recovers As Phase II Trial Is Salvaged

Peregrine Recovers As Phase II Trial Is Salvaged

Seeking Alpha

Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup

Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup

TheStreet.com

3 Companies With Exciting Phase II Trial Data Close Out 2012

3 Companies With Exciting Phase II Trial Data Close Out 2012

Seeking Alpha

Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT

Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT

Wall Street Cheat Street

This New Cancer Drug is Boosting Peregrine Pharmaceuticals 48%!

This New Cancer Drug is Boosting Peregrine Pharmaceuticals 48%!

Wall Street Cheat Street

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September

Gilead, Salix, Peregrine, Navidea Approach Key Dates In September

Minyanville